2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid

C214H256B2F3N37O24 — CID 160513944

About 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid

2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid (PubChem CID 160513944) has the molecular formula C214H256B2F3N37O24 and a molecular weight of 3809.25 g/mol. Its IUPAC name is 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid.

Molecular Properties

• Compound Name: 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid
• PubChem CID: 160513944
• Molecular Formula: C214H256B2F3N37O24
• Molecular Weight: 3809.25 g/mol
• Exact Mass: 3807.01
• IUPAC Name: 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid
• SMILES: CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)NCC3OB(O)c4cc(NC(=O)OCc5ccccc5)ccc43)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)NCC3OB(O)c4ccccc43)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cnc4c(c3)CCC(C)C4)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cnc4c(c3)CN(Cc3ccccc3)CC4)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cnc4c(c3)CNCC4)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cncc(CCC(=O)CCCc4ccccc4)c3)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cncc(CCC(=O)[C@@H](N)C(C)C)c3)cc2N=C(N)C1.O=C(O)C(F)(F)F
• InChI: InChI=1S/C35H41N5O3.C34H38BN5O6.C33H38N6O2.C30H40N6O3.C28H35N5O2.C26H31BN4O4.C26H32N6O2.C2HF3O2/c1-3-17-40(18-4-2)35(43)29-20-27-14-15-28(21-32(27)39-33(36)22-29)34(42)38-30-19-26(23-37-24-30)13-16-31(41)12-8-11-25-9-6-5-7-10-25;1-3-14-40(15-4-2)33(42)25-16-23-10-11-24(17-29(23)39-31(36)18-25)32(41)37-20-30-27-13-12-26(19-28(27)35(44)46-30)38-34(43)45-21-22-8-6-5-7-9-22;1-3-13-39(14-4-2)33(41)26-16-24-10-11-25(18-30(24)37-31(34)19-26)32(40)36-28-17-27-22-38(15-12-29(27)35-20-28)21-23-8-6-5-7-9-23;1-5-11-36(12-6-2)30(39)23-14-21-8-9-22(15-25(21)35-27(31)16-23)29(38)34-24-13-20(17-33-18-24)7-10-26(37)28(32)19(3)4;1-4-10-33(11-5-2)28(35)22-13-19-8-9-21(15-25(19)32-26(29)16-22)27(34)31-23-14-20-7-6-18(3)12-24(20)30-17-23;1-3-11-31(12-4-2)26(33)19-13-17-9-10-18(14-22(17)30-24(28)15-19)25(32)29-16-23-20-7-5-6-8-21(20)27(34)35-23;1-3-9-32(10-4-2)26(34)19-11-17-5-6-18(13-23(17)31-24(27)14-19)25(33)30-21-12-20-15-28-8-7-22(20)29-16-21;3-2(4,5)1(6)7/h5-7,9-10,14-15,19-21,23-24H,3-4,8,11-13,16-18,22H2,1-2H3,(H2,36,39)(H,38,42);5-13,16-17,19,30,44H,3-4,14-15,18,20-21H2,1-2H3,(H2,36,39)(H,37,41)(H,38,43);5-11,16-18,20H,3-4,12-15,19,21-22H2,1-2H3,(H2,34,37)(H,36,40);8-9,13-15,17-19,28H,5-7,10-12,16,32H2,1-4H3,(H2,31,35)(H,34,38);8-9,13-15,17-18H,4-7,10-12,16H2,1-3H3,(H2,29,32)(H,31,34);5-10,13-14,23,34H,3-4,11-12,15-16H2,1-2H3,(H2,28,30)(H,29,32);5-6,11-13,16,28H,3-4,7-10,14-15H2,1-2H3,(H2,27,31)(H,30,33);(H,6,7)/t;;;28-;;;;/m...0..../s1
• InChIKey: LOTRFNURBGFYET-PIUSGECYSA-N
• XLogP: 31.11
• TPSA: 888.96 Ų
• H-Bond Donors: 20
• H-Bond Acceptors: 45
• Rotatable Bonds: 68
• Heavy Atoms: 280
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3809.25
LogP ≤ 5	31.11
H-Bond Donors ≤ 5	20
H-Bond Acceptors ≤ 10	45

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid?

The IUPAC name of 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid (CID 160513944) is 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid.

What is the SMILES notation for 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid?

The canonical SMILES for 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid is CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)NCC3OB(O)c4cc(NC(=O)OCc5ccccc5)ccc43)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)NCC3OB(O)c4ccccc43)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cnc4c(c3)CCC(C)C4)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cnc4c(c3)CN(Cc3ccccc3)CC4)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cnc4c(c3)CNCC4)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cncc(CCC(=O)CCCc4ccccc4)c3)cc2N=C(N)C1.CCCN(CCC)C(=O)C1=Cc2ccc(C(=O)Nc3cncc(CCC(=O)[C@@H](N)C(C)C)c3)cc2N=C(N)C1.O=C(O)C(F)(F)F.

What is the InChIKey of 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid?

The InChIKey is LOTRFNURBGFYET-PIUSGECYSA-N. The full InChI is InChI=1S/C35H41N5O3.C34H38BN5O6.C33H38N6O2.C30H40N6O3.C28H35N5O2.C26H31BN4O4.C26H32N6O2.C2HF3O2/c1-3-17-40(18-4-2)35(43)29-20-27-14-15-28(21-32(27)39-33(36)22-29)34(42)38-30-19-26(23-37-24-30)13-16-31(41)12-8-11-25-9-6-5-7-10-25;1-3-14-40(15-4-2)33(42)25-16-23-10-11-24(17-29(23)39-31(36)18-25)32(41)37-20-30-27-13-12-26(19-28(27)35(44)46-30)38-34(43)45-21-22-8-6-5-7-9-22;1-3-13-39(14-4-2)33(41)26-16-24-10-11-25(18-30(24)37-31(34)19-26)32(40)36-28-17-27-22-38(15-12-29(27)35-20-28)21-23-8-6-5-7-9-23;1-5-11-36(12-6-2)30(39)23-14-21-8-9-22(15-25(21)35-27(31)16-23)29(38)34-24-13-20(17-33-18-24)7-10-26(37)28(32)19(3)4;1-4-10-33(11-5-2)28(35)22-13-19-8-9-21(15-25(19)32-26(29)16-22)27(34)31-23-14-20-7-6-18(3)12-24(20)30-17-23;1-3-11-31(12-4-2)26(33)19-13-17-9-10-18(14-22(17)30-24(28)15-19)25(32)29-16-23-20-7-5-6-8-21(20)27(34)35-23;1-3-9-32(10-4-2)26(34)19-11-17-5-6-18(13-23(17)31-24(27)14-19)25(33)30-21-12-20-15-28-8-7-22(20)29-16-21;3-2(4,5)1(6)7/h5-7,9-10,14-15,19-21,23-24H,3-4,8,11-13,16-18,22H2,1-2H3,(H2,36,39)(H,38,42);5-13,16-17,19,30,44H,3-4,14-15,18,20-21H2,1-2H3,(H2,36,39)(H,37,41)(H,38,43);5-11,16-18,20H,3-4,12-15,19,21-22H2,1-2H3,(H2,34,37)(H,36,40);8-9,13-15,17-19,28H,5-7,10-12,16,32H2,1-4H3,(H2,31,35)(H,34,38);8-9,13-15,17-18H,4-7,10-12,16H2,1-3H3,(H2,29,32)(H,31,34);5-10,13-14,23,34H,3-4,11-12,15-16H2,1-2H3,(H2,28,30)(H,29,32);5-6,11-13,16,28H,3-4,7-10,14-15H2,1-2H3,(H2,27,31)(H,30,33);(H,6,7)/t;;;28-;;;;/m...0..../s1.

What are the key properties of 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid?

2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid has a molecular weight of 3809.25 g/mol, XLogP of 31.11, 68 rotatable bonds, 20 hydrogen bond donors, and 45 hydrogen bond acceptors.

Where does this data come from?

All data for 2-amino-8-N-[5-[(4S)-4-amino-5-methyl-3-oxohexyl]-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(6-benzyl-7,8-dihydro-5H-1,6-naphthyridin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-4-N,4-N-dipropyl-8-N-(5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-(7-methyl-5,6,7,8-tetrahydroquinolin-3-yl)-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;2-amino-8-N-[5-(3-oxo-6-phenylhexyl)-3-pyridinyl]-4-N,4-N-dipropyl-3H-1-benzazepine-4,8-dicarboxamide;benzyl N-[3-[[[2-amino-4-(dipropylcarbamoyl)-3H-1-benzazepine-8-carbonyl]amino]methyl]-1-hydroxy-3H-2,1-benzoxaborol-6-yl]carbamate;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 160513944), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).